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Estrogens are defined by their ability to induce the proliferation of cells of the female genital tract. The wide chemical diversity of estrogenic
compounds precludes an accurate prediction of estrogenic activity on the basis of chemical structure. Rodent bioassays are not suited for the
large-scale screening of chemicals before their release into the environment because of their cost, complexity, and ethical concerns. The E-SCREEN
assay was developed to assess the estrogenicity of environmental chemicals using the proliferative effect of estrogens on their target cells as an
end point. This quantitative assay compares the cell number achieved by similar inocula of MCF-7 cells in the absence of estrogens (negative
control) and in the presence of 17,B-estradiol (positive control) and a range of concentrations of chemicals suspected to be estrogenic. Among the
compounds tested, several "new" estrogens were found; alkylphenols, phthalates, some PCB congeners and hydroxylated PCBs, and the
insecticides dieldrin, endosulfan, and toxaphene were estrogenic by the E-SCREEN assay. In addition, these compounds competed with estradiol
for binding to the estrogen receptor and increased the levels of progesterone receptor and pS2 in MCF-7 cells, as expected from estrogen mimics.
Recombinant human growth factors (bFGF, EGF, IGF-1) and insulin did not increase cell yields. The aims of the work summarized in this paper were
a) to validate the E-SCREEN assay; b) to screen a variety of chemicals present in the environment to identify those that may be causing reproductive
effects in wildlife and humans; c) to assess whether environmental estrogens may act cumulatively; and finally d) to discuss the reliability of this
and other assays to screen chemicals for their estrogenicity before they are released into the environment. - Environ Health Perspect 103(Suppl
7):113-122 (1995)
Key words: xenobiotics, cell proliferation, endosulfan, phthalates, antioxidants, alkylphenols
Introduction
For the last 40 years, substantial evidence
has surfaced on the hormonelike effects of
many xenobiotics in fish, wildlife, and
humans (1). The endocrine and reproduc-
tive effects ofxenobiotics are believed to be
due to their a) mimicking effects of
endogenous hormones such as estrogens
and androgens; b) antagonizing the effects
of normal, endogenous hormones; c) alter-
ing the pattern ofsynthesis and metabolism
of natural hormones; and d) modifying
hormone receptor levels.
Among environmental chemicals found
to cause reproductive impairment in
wildlife and humans there are estrogen
mimics (xenoestrogens). Natural estrogens
promote cell proliferation and hypertrophy
offemale secondary sex organs and induce
the synthesis of cell type-specific proteins
(2). Xenobiotics ofwidely diverse chemical
structure have estrogenic properties (3,4).
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This diversity makes it difficult to predict
the estrogenicity of xenobiotics solely on
structural bases. To overcome this short-
coming, their identification as estrogens has
relied on rodent bioassays. These assays
measure either vaginal cornification or the
increase in uterinewetweight; however, the
latter is not a specific estrogen response (5).
To obviate problems inherent to animal
testing, quantitative bioassays using cells in
culture have been developed. For example,
the induction ofprolactin in primary sheep
pituitary cell culture has been proposed as a
measure of estrogen action (6); in this
model, estrogens induce protein synthesis
but are ineffective at inducing cell prolifera-
tion. The limitations of this assay are that
some estrogen-inducible genes could also be
induced by nonestrogenic substances. For
example, prolactin synthesis may be
induced by EGF, thyrotropin releasing fac-
tor, and phorbol esters (7). Another estro-
gen-inducible marker, ovalbumin synthesis,
is stimulated byother steroids such as prog-
esterone and glucocorticoids (8). Also,
induction of reporter genes under control
by estrogen-responsive elements has been
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proposed to assess estrogenicity; however,
elevated basal expression in the absence of
estrogen often occurs, and this may raise
concern about the reliability ofthese assays.
Therefore, the proliferative effect ofnatural
estrogens on the female genital tract
remains the hallmark ofestrogen action.
Hertz argued convincingly that this
proliferative property should be adopted as
the one method to determine whether or
not a chemical is an estrogen (2). This
requires measuring the increase of mitotic
activity in tissues ofthe female genital tract
after estrogen administration. However,
this method is not suitable for large-scale
screening of suspected chemicals and an
equally reliable, easy, and rapid-to-perform
method would be preferable. The novel
E-SCREEN assay fulfills these require-
ments (9). This assay measures estrogen-
induced increase ofthe number ofhuman
breast MCF-7 cells and is recognized as
biologically equivalent to the increase of
mitotic activity in the rodent endometrium
(9,10). The objectives ofthis studywere to
validate the E-SCREEN assay and to test
the estrogenicity ofchemicals released into
the environment in largevolumes.
Materials and Methods
Cell LineandCell Culture Conditions
Human breast cancer estrogen-sensitive
MCF-7 cells were obtained from the
Michigan Cancer Foundation (Detroit,
MI) (11). For routine maintenance, cells
were grown in Dulbecco's modification of
Eagle's medium (DME) (GIBCo, Grand
Island, NY) supplemented with 5% fetal
bovine serum (FBS) (Hyclone, Logan, UT)
at 37°C in an atmosphere of5% C02/95%
air under saturating humidity.
Steroids,Xenobiotics, and
GrowthFactorsTested
17,-Estradiol (E2) was obtained from
Calbiochem (Richmond, CA). Other
steroids were purchased from Steraloids
(Keene, NH). R26008 (allenolic acid) was
supplied by Roussel-UCLAF, Romainville,
France. Toxaphene (technical grade) and
endosulfan (technical grade) were obtained
from Chem Services (West Chester, PA).
Endosulfan a and P isomers, o,p'-DDT,
p,p'-DDT, p,p'-DDD, p,p'-DDE, PCB
congeners, methoxychlor, dieldrin, phtha-
late esters, and antioxidants were from
Ultra Scientific (North Kingstown, RI).
Hydroxylated biphenyls were a gift from J.
A. McLachlan (National Institute of
Environmental Health Sciences, Research
Triangle Park, NC [NIEHS]). DES metab-
olites were a gift ofK.S. Korach (NIEHS).
Estradiol was stored as a 1-mM stock solu-
tion in ethanol at -20°C. Pesticides were
dissolved in ethanol to a final concentra-
tion of 10 mM, except endosulfan mixed
isomers, dieldrin, and toxaphene, which
were dissolved in dimethyl sulfoxide
(DMSO); they were all diluted to desired
concentrations in phenol red-free DME
immediately before using. The final solvent
concentration in culture medium did not
exceed 0.1%; this concentration did not
affect cell yields. Human recombinant
EGF, basic FGF, and IGF-1 were pur-
chased from Collaborative Research
(Lexington, MA).
Plasma-derivedandBlood-derived
Human Serum
Plasma-derived human serum was prepared
from outdated plasma supplied by the New
England Medical Center Blood Bank,
(Boston, MA). Calcium chloride was added
to a final concentration of30 mM to facili-
tate clot formation. Blood-derived serum
was obtained using blood from healthy
adult volunteers; blood was allowed to clot
in glass centrifuge tubes for 2 to 4 hr to
obtain serum. Plasma- and blood-derived
serum were clarified by centrifugation
(2000xg for 10 min), heat-inactivated
(56°C for 30 min), centrifuged, charcoal-
dextran stripped, and stored in glass tubes
at-20°C until use.
RemovalofSexSteroids by
Charcoal-DextranTreatmentofSerum
Charcoal (Norit A, acid washed; Sigma
Chemical Co, St. Louis, MO) was washed
twice with cold sterile water immediately
before using. A 5% charcoal-0.5% dextran
T70 (Pharmacia-LKB, Uppsala, Sweden)
suspension was prepared. Charcoal-dex-
tran (CD) suspension aliquots ofa volume
similar to the serum aliquots to be
processed were centrifuged at 2500 rpm for
10 min. Supernatants were aspirated and
serum aliquots were mixed with the char-
coal pellets. This charcoal-serum mixture
was maintained in suspension by rolling at
4 cycles/min at 370C for 1 hr. This suspen-
sion was centrifuged at 2000xgfor 20 min.
The supernatant was then filtered through
a 0.45-pm Nalgene filter. Over 99% of
serum sex steroids were removed by this
treatment when determined by removal of
3H-E2 (12); E2 levels after CD treatment
were less than 0.01 pg/ml when measured
by radioimmunoassay. CD sera were stored
at -20°C until needed. Samples kept for 1
year in the freezer maintained their
inhibitory properties on the proliferation
of human estrogen-sensitive breast tumor
MCF-7 cells; plasma- and blood-derived
serawere equally effective.
TheE-SCREENTest
The E-SCREEN assay was developed based
on the following premises: a) a human
serum-borne molecule specifically inhibits
the proliferation of human estrogen-sensi-
tive cells (12-16); and b) estrogens induce
cell proliferation by canceling this
inhibitory effect (12,13,16). Nonestrogenic
steroids and growth factors did not abolish
the proliferative inhibition by mammalian
serum (12,13).
Cloned MCF-7 cells were trypsinized
and plated into 12-well plates (Costar,
Cambridge, MA) at initial concentrations
of 20,000 cells per well (9,10). Cells were
allowed to attach for 24 hr; then, the seeding
medium (5% FBS in DME) was removed
and replaced by the experimental medium
[5% CD human serum supplemented to
phenol red-free DME (CDHuS)]. A range
ofconcentrations ofthe test compounds was
added to this medium. The bioassay was
terminated on day 6 (late exponential
phase) by removing the media from the
wells, adding a cell lysing solution (10%
ethylhexadecyl-dimethylammonium bro-
mide [Eastman Kodak Co., Rochester,
NY] in 0.5% Triton X-100, 2 mM MgCl2,
15 mM NaCl, 5 mM phosphate buffer,
pH 7.4) and counting the nuclei in a
Coulter Counter Apparatus, Model ZM
(Coulter Electronics, Hialeah, FL).
The best estimate of the proliferative
behavior of a cell population is td or dou-
bling time. td is the time interval in which
an exponentially growing culture doubles
its cell number. Determining td requires
measuring cell yields at several time inter-
vals during the exponential proliferation
phase. A less cumbersome alternative to
measuring proliferation rates is comparing
the cell yield achieved by similar cell inocu-
la harvested simultaneously during the late
exponential phase of proliferation. The
proliferative effect (PE) is measured as the
ratio between the highest cell yield
obtained with the test chemical and with
the hormone-free control. Under these
experimental conditions, cell yield repre-
sents a reliable estimate ofthe relative pro-
liferation rate achieved by similar inocula
exposed to different proliferation regula-
tors. In our experimental design, MCF-7
cell yields were measured 6 days after to;
however, significant differences between
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control and estrogen-treated cultures are
apparent after 4 days (16).
The estrogenic activity of xenobiotics
was assessed a) by determining their relative
proliferative potency (RPP), which mea-
sures the ratio between the minimal con-
centration of estradiol needed for maximal
cell yield and the minimal dose of the test
compound needed to achieve a similar
effect; and b) by measuring their relative
proliferative effect (RPE), which is 100
times the ratio between the highest cell
yield obtained with the chemical and with
E2. RPE is calculated as 100x(PE-1) ofthe
test compound/(PE-1) of E2. Thus, the
RPE indicates whether the compound
being tested induces a proliferative response
quantitatively similar to the one obtained
with E2, that is, a full agonist (RPE= 100),
or a proliferative yield significantly lower
than the one obtained with E2, that is, a
partial agonist (9). Figure 1 displays a
schematic representation of these concepts.
For screening purposes, the range ofxenobi-
otic concentrations was from 1 nM to 10
pM, and for E2 from 0.1 pM to 1 nM, mea-
sured at intervals ofone order ofmagnitude.
Progesterone ReceptorAssayand
Estrogen Receptor Processing
MCF-7 cells were seeded in 25-cm2 flasks
in 5% FBS-supplemented DME. Twenty-
four hours later, the medium was changed
to 5% CDHuS, and the chemicals to be
tested were added. Control flasks were
treated with vehicle. After 72 hr of expo-
sure to the test xenoestrogens, medium was
aspirated, the cell layer was rinsed with
PBS, and the cells were frozen in liquid
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Figure 1. Schematic representation ofthe dose-response
curve to E2(-*-), a full agonist (-O-), and a par-
tial agonist (-A-). The horizontal bars indicate that
RPP is a comparison between effective concentrations of
the agonist and E2. The vertical bars at the right of the
graph box illustrate that RPE compares the ability of E2
and of agonists to increase the cell yield overthe values
obtained in untreated controls. The RPE ofthefull agonist
in this figure is 100, that is, lOOx(500/100)-
1(500/100)-l. The RPE of the partial agonist is 37.5,
that is, 100x(250/100)-1/(500/100)-1.
N2. To extract receptor molecules, cells
were incubated with 1 ml of extraction
buffer (0.5 M KCI, 10 mM potassium
phosphate, 1.5 mM EDTA, and 1 mM
monothioglycerol, pH 7.4) at 40C for
30 min (17). After centrifugation to pellet
the cell debris, receptor levels were mea-
sured in 100--pl extract aliquots by enzyme
immunoassay using the Abbott estrogen
and progesterone receptors kits (Abbott
Diagnostics, Chicago, IL) according to the
manufacturer's instructions.
pS2Assay
Culture media were harvested after 72 hr
of exposure to the test chemicals and cen-
trifuged to eliminate floating and detached
cells; samples were kept frozen at -80°C
until the immunoradiometric assay was
performed following the manufacturer's
protocol (ELSA-PS2, CIS Bio Inter-
national, Gif-sur-Yvette, France).
Determination ofRelative
BindingAffinities
MCF-7 cells were grown in 150-cm2 flasks
in 5% FBS; they were harvested during the
late exponential phase after 24 hr of expo-
sure to 5% CDHuS. Cells were rinsed with
PBS, and a suspension of 20x 106 cells/ml
of buffer (500 mM KCl, 1.5 mM EDTA,
10 mM Tris-HCl, pH 7.4, at 40C) was
sonified at 40C (5-sec pulses with 30-sec
intervals). The cell homogenate was cen-
trifuged at 100,OOOxg for 40 min, and
supernatant aliquots were incubated with 2
nM 3H-E2 alone and in combination with
unlabeled competitors at concentrations
ranging from 1 pM to 1 pM E2 or 1 nM to
1 mM xenoestrogens for 16 hr at 40C. The
reaction mixture contained 15% DMSO
to solubilize hydrophobic xenoestrogens.
This treatment did not alter the shape of
the competition curve for E2 and nonyl-
phenol, the only two compounds from
which a competition curve could be
obtained in the absence of DMSO.
Separation ofbound and free hormone was
done by CD adsorption (18).
StatisticalAaysis
Results were expressed as the mean ± SE.
Proliferation yield experiments conducted
in duplicate wells were repeated at least a
minimum of 5 times. Mean cell numbers
from each experiment were normalized to
the steroid-free control (100%) to correct
for differences in the initial plating den-
sity. Differences between the diverse
steroid treatment groups were assessed by
analysis of variance and the a posteriori
Shaffe's test (19). A p value of <0.05 was
regarded as significant.
Results
ProliferativeEffectofCompounds
KnownTo BeEstrogenic
inAnimalModels
E2 induced maximal cell yields at 10 to
100 pM using the E-SCREEN assay.
Twenty-two compounds reported to have
estrogenic activity were also tested. Their
RPP is listed in Table 1. Their relative
potency measured by the E-SCREEN assay
correlated with their relative binding
affinity to the estrogen receptor and with
their biological effect in uterotropic assays.
Exceptions to these correlations have been
reported in the literature; they reflect rates
of clearance and metabolization of estro-
gens (20). The E-SCREEN assay mimics
exposure to a constant level of hormone,
much like that achieved in animals by
using estrogen-filled silastic implants.
Estriol behaved as a full agonist in the E-
SCREEN assay as it did when adminis-
tered to animals in multiple doses (21).
Similarly, the proliferative potency ofDES
metabolites measured by the E-SCREEN
assay paralleled that in the uterotropic
assay; however, pseudo-DES and indane-
strol had poor uterotropic activity but were
full agonists when assayed by the
E-SCREEN test (RPP = 10). The lowered
Table 1. Proliferative effect of diverse estrogens mea-
sured bythe E-SCREEN assay.
Compound RPP, %
17j-Estradiol 100
17a-Estradiol 10
Estrone 1
Estriol 10
Moxestrol 1000
16-Hydroxyestrone 0.1
Diethylstilbestrol (DES) 1000
cis-Tamoxifen 0.001
Metabolite E (from tamoxifen) 0.001
R26008 0.1
11 3-Chloromethylestradiol 1000
Indanestrol 10
Indenestrol-A 100
Indenestrol-B 10
Pseudo-DES 0.1
Pseudo-DES-e 10
Pseudo-DES-z 10
Zearalenol 1
Zearalenone 1
d-Equilenin 1
Coumestrol 0.001
Ethynyl-estradiol 100
Relative proliferative potency (RPP) is the ratio
between 170-estradiol and xenoestrogen doses
needed to produce maximal cell yields x 100.
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estrogenic potency ofthese two compounds
was attributed to slow processing or clear-
ance of the ligand-bound receptor (20).
This notion is at variance with the data dis-
cussed below regarding alkylphenols,
which are active both in uterotropic and E-
SCREEN assays, while displaying dimin-
ished processing ofestrogen receptors.
Nonestrogenic compounds (natural and
synthetic progestagens, glucocorticoids, and
pesticide derivatives such as mirex, chlor-
dane-a isomer, chlordane, and heptachlor)
did not affect the proliferation of MCF-7
cells. No false positives were observed.
Moreover, insulin, transferrin, and EGF
did not reverse the inhibitory effect of
serum (12,13,16). This conclusion was val-
idated further by using human recombinant
bFGF, EGF, and IGF-1 (Table 2). These
results strengthen the reliability and
specificity ofthis "in culture" assay.
Identification ofNewXenoestrogens
amongAntioxidants and Plasticizers
An estrogenic contaminant was isolated
from modified polystyrene centrifuge tubes
(Corning Glass Co., Corning, NY, Cat.
No. 25310-15). After purification by flash
chromatography and reverse-phase HPLC,
the estrogenic compound was identified by
gas chromatography-mass spectrometry as
a p-nonylphenol isomer (10). This nonyl-
phenol was a full estrogen for MCF-7 cells
(RPE=100; RPP=0.0003 %, Table 3).
Nonylphenol also increased the mitotic
index of the endometrial epithelium in
adult ovariectomized rats. As expected
from a genuine estrogen, it also induced
progesterone receptor in MCF-7 cells.
p-Nonylphenol is 10 to 50 times more
potent an estrogen than kepone and
o,p'-DDT, and it mimics both the prolifer-
ative and inductive properties of natural
estrogens. Alkylphenols with at least a
three-carbon alkyl chain were also found to
be estrogenic; p-octylphenol was the more
potent one (RPP =0.03). Other phenolic
antioxidants were tested; among them
Table 2. Effect of recombinant human growth factors
on the proliferation of MCF-7 cells grown in medium
containing 5% charcoal-dextran stripped human serum
(CDHuS).
Compound Concentration Cell number
Control, 5% CDHuS - 38,140 ±5,900
5% CDHuS + estradiol 10 pM 214,120 ±3,400
5% CDHuS + bFGF 10 ng/ml 27,310 ±285
5% CDHuS + EGF 10 ng/ml 29,820 ±2,844
5% CDHuS + IGF-1 10 ng/ml 49,140 ±1,519
Cells were harvested after 6 days of exposure to the
experimental media.
polyalkylated, hindered phenols such as
butylated hydroxytoluene (BHT) and
Irganox 1640 were not estrogenic, whereas
t-butylhydroxyanisole (BHA) was estro-
genic. Among phthalate esters used as plas-
ticizers, those derived from alkylalcohols
such as dibutylphthalate and diamylphtha-
late were not estrogenic, whereas butylben-
zylphthalate was estrogenic.
Identification ofEstrogenic
PCB Congeners
Aroclor 1221 (9), 18 PCB congeners, and
10 hydroxylated PCBs were tested (Table
4). Five PCB congeners were estrogenic in
the E-SCREEN assay indicating that they
are estrogenic per se or they have under-
gone hydroxylation by MCF-7 cells; their
RPP was 0.0001. None of the estrogenic
PCBs was coplanar. Among the hydroxy-
lated PCBs assayed, the most potent were
2',5'-dichloro-4-hydroxybiphenyl,
(RPP=0.01-0.001), 2',4',6'-trichloro-4-
hydroxybiphenyl (RPP=0.01), and
2',3',4',5'-tetrachloro-4-hydroxybiphenyl
(RPP=0.001). 2',5'-dichloro-3-hydroxy-
biphenyl and 2',3',4',5'-tetrachloro-3-
hydroxybiphenyl were also estrogenic,
albeit 10-fold less potent than their 4-
hydroxy isomers (Figure 2). More con-
geners should be assayed to derive
meaningful structure-activity relationships
among the 209 PCB congeners and their
metabolites; the E-SCREEN assay should
facilitate this undertaking.
IdentificationofEstrgenicPesticides
Table 5 lists a number of pesticides and
industrial chemicals assayed by the E-
SCREEN test. None ofthe herbicides and
fungicides tested were estrogenic. The
estrogenicity of DDT, its metabolites,
and chlordecone was confirmed by the
E-SCREEN test. Among DDT isomers,
o,p'-DDT was slightly more potent than
p,p'-DDT, showing significant activity at
1 pM, albeit lower than at 10 pM; p,p'-
DDT showed estrogenic activity only at
10 pM. Methoxychlor was expected to be
inactive in the E-SCREEN assay because it
requires metabolic activation, probably in
the liver. However, methoxychlor (98%
pure, U.S. EPA standard) and p,p'-meth-
oxychlor (99.6% pure) induced the prolif-
eration of MCF-7 cells. From these data
we infer that MCF-7 cells have the enzy-
matic complement necessary to activate
proestrogens. Comparable results were
reported by White et al. (22) regarding
alkylphenol diethoxylates. A heptachlor
derivative, 1-hydroxychlordene, showed
submaximal estrogenic activity (RPE=40)
at 10 pM. Technical grade endosulfan and
a and ,B endosulfan isomers were estrogenic
Table 3. Estrogenic effect of industrial chemicals measured bythe E-SCREEN assay.
Compound Concentrationa RPE, %C RPP, %d
Estradiol 30 pM 100 100
Phenol 10PMb 0
4-Ethylphenol 10 pMb 5
4-Propylphenol 10pM 17
4-sec-Butylphenol 10pM 76 0.0003
4-tert-Butylphenol 10 pM 71 0.0003
4-tert-Pentylphenol 10pM 105 0.0003
4-Isopentylphenol 10pM 93 0.0003
4-Butoxyphenol 10 pMb 0
4-Hexyloxyphenol 10 pMb 0
4-Hydroxybiphenyl 10 pM 87 0.0003
4,4'-Dihydroxybiphenyl 10 pM 84 0.0003
1-Naphthol 10 pMb 0
2-Naphthol 10 pMb 0
5,6,7,8-Tetrahydronaphthol-2 10 pMb 0
6-Bromonaphthol-2 10 PM 38
5-Octylphenol 100 nM 100 0.03
4-Nonylphenol 1 pM 100 0.003
Nonylphenol, technical grade 10 pM 102 0.0003
t-Butylhydroxyanisole 50 pM 30 0.00006
Benzylbutylphthalate 10 pM 90 0.0003
'The lowest concentration needed for maximal cell yield. bIndicates the highest concentration tested in culture.
cThe relative proliferative effect is calculated as 100x(PE-1) of the test compound/(PE-1) of E2; a value of 100
indicates that the compound tested is a full agonist, a value of 0 indicates that the compound lacks estrogenicity
at the doses tested, and intermediate values suggest that the xenobiotic is a partial agonist. dRelative prolifera-
tive potency is the ratio between E2 and xenobiotic doses needed to produce maximal cell yields x100. All com-
pounds designated as full or partial agonists increased cell yields significantly over the hormoneless control
(p<0.05).
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Table 4. Estrogenic effect of polychlorinated biphenyl (PCB) congeners and hydroxylated PCBs measured by the
E-SCREEN assay.
Compound Name Concentrationa RPE, %C RPP, %d
1 2-Monochlorobiphenyl lopMb 4.4
2 4-Monochlorobiphenyl 10 PMb 2.1 -
3 2,5-Dichlorobiphenyl 10 pMb 3.7 -
4 2,6-Dichlorobiphenyl 10 pMb 3.4 -
5 3,5-Dichlorobiphenyl 10 pMb 2.7 -
6 2,3,4-Trichlorobiphenyl 10 pM 77.0 0.0001
7 2,3',5-Trichlorobiphenyl 10 pMb 2.2 -
8 2,3,6-Trichlorobiphenyl 10 PMb 5.8 -
9 2,2',4,5-Tetrachlorobiphenyl 10 pM 61.6 0.0001
10 2,3,4,4'-Tetrachlorobiphenyl 10 pMb 4.7 -
11 2,3,4,5-Tetrachlorobiphenyl 10 pM 39.2 0.0001
12 2,3,5,6-Tetrachlorobiphenyl 10 pMb 3.1 -
13 2,4,4',6-Tetrachlorobiphenyl 10 PM 75.7 0.0001
14 2,3,3',4,5-Pentachlorobiphenyl 10 pMb 1.0 -
15 2,3,4,5,6-Pentachlorobiphenyl 10 pMb 4.4
16 2,2',3,3',5,5'-Hexachlorobiphenyl 10 pMb 1.0 -
17 2,2',3,3',6,6'-Hexachlorobiphenyl 10 PM 61.6 0.0001
18 Decachlorobiphenyl 10 pMb 3.5 -
19 2',5'-Dichloro-2-hydroxybiphenyl 10 pM 13.0 0.0001
20 2',5'-Dichloro-3-hydroxybiphenyl 10 PM 69.9 0.0001
21 2',5'-Dichloro-4-hydroxybiphenyl 1 pMe 71.2 0.001
22 3,5-Dichloro-2-hydroxybiphenyl 10 pMb 5.4 -
23 3,5-Dichloro-4-hydroxybiphenyl 10 pMb 1.5 -
24 2,2', 5-Trichloro-4-hydroxybiphenyl 1 pM 37.8 0.001
25 2',4',6'-Trichloro-4-hydroxybiphenyl 100 nM 99.8 0.01
26 2',3',4',5'-Tetrachloro-3-hydroxybiphenyl 10 PM 35.3 0.0001
27 2',3',4',5'-Tetrachloro-4-hydroxybiphenyl 1 pM 92.0 0.001
28 2',3',4',5,5'-Pentachloro-2-hydroxybiphenyl 10 pMb 4.8 -
aIndicates the lowest concentration needed for maximal cell yield. bIndicates the highest concentration tested in
culture. CRelative proliferative effect is calculated as 100x(PE-1) ofthe test compound/(PE-1) of E2; a value of 100
indicates that the compound tested is a full agonist, a value of 0 indicates that the compound lacks estrogenicity
at the doses tested, and intermediate values suggest that the xenobiotic is a partial agonist. dRelative prolifera-
tive potency is the ratio between E2 and xenobiotic doses needed to produce maximal cell yields x 100. All com-
pounds designated as full or partial agonists increased cell yields significantly over the hormoneless control
(p<0.05). 'This compound exhibited submaximal proliferative activity at 100 nM (RPE:62%).
450-
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Figure 2. Proliferative activity of HC, hormoneless
control; A, estradiol; B, 2',5',2-hydroxy-DCB; C, 2',5',3-
hydroxy-DCB; D, 2',5',4-hydroxy-DCB; E, 2',3',4',5',3-
hydroxy-TCB; and F, 2',3',4',5',4-hydroxy-TCB.
Asterisks (*) indicate significant differences with hor-
moneless control (p<0.05).
at concentrations of 10 to 25 pM. It
should be noted that the RPE of all these
chemicals is lower than that of estradiol
(endosulfanmixed isomers RPE 81%,
a isomer RPE=77%, 3 isomer RPE 78%)
(Table 6). Dieldrin and toxaphene were
found to be estrogenic at 10 pM. The
RPEs ofthese compounds were lower than
those of endosulfan (dieldrin, RPE=55%;
toxaphene, RPE= 52%) (23). The fact that
these compounds have toxic effects at con-
centrations one order ofmagnitude higher
than those needed to evoke a proliferative
response precluded assessing whether
higher concentrations would attain full
estrogenic activity in this bioassay.
InductionofProgserone Receptor
andpS2bytheNewlyIdentified
X oestogns
Pesticides found to be estrogenic by the
E-SCREEN assay were also effective induc-
ers of markers of estrogen action such as
progesterone receptors (PR) and pS2 in
MCF-7 cells (Table 7). Dieldrin signifi-
cantly increased pS2 levels; PR levels
increased slightly at the maximal dose
tested (10 IM). Dieldrin is toxic at concen-
trations higher than 10 pM; this preduded
testing whether higher concentrations
would result in full induction of PR.
Nonylphenol (J0) and octylphenol (22)
also induced PR.
Xenoestrogens andthe Prssing
ofEstrogen Receptors
Estradiol treatment of MCF-7 cells for a
period of72 hr decreased the level ofestro-
gen receptors by 50% (receptor process-
ing); this effect is interpreted by some as an
important step on estrogen action (24).
Others have reported that the proliferative
effect ofestradiol also occurs in the absence
of processing (25). Treatment with xeno-
estrogens such as endosulfan, toxaphene,
dieldrin (Table 8), and nonylphenol (not
shown) did not decrease estrogen receptor
levels in MCF-7 cells; to the contrary, a
slight increase ofup to 57% was recorded.
CompetitiveBindingtothe
Estrgn Receptor
o,p'-DDT, endosulfan, toxaphene, and
nonylphenol competed with 3H-E2 for
binding to the receptor; their relative
binding affinities correlated with their rel-
ative proliferative potency. Table 9 com-
pares the relative binding affinities ofthese
xenoestrogens, their IC50 values and their
relative proliferative potency. The concen-
tration ofestradiol and xenoestrogens nec-
essary to decrease 3H-E2 binding by 50%
were about one order ofmagnitude higher
than the concentration needed to achieve
maximal cell proliferation yields, PR and
pS2 induction.
Cumulative EffectofXnoestogens
Analysis of fat or serum from wildlife and
humans often reveals the simultaneous
presence ofseveral xenoestrogens (1); these
findings suggest that xenoestrogens may act
cumulatively. By using the E-SCREEN
assay we verified this suggestion. Figure 3
shows the additive effect of 10 xenoestro-
gens, each administered at one tenth ofthe
minimal effective dose that produces a
proliferative effect.
Discussion
The deleterious impact ofxenoestrogens on
the reproductive success, development, and
health of animals is well documented; the
realization that humans are also exposed
and at risk has become increasingly obvious
(26). Data showing a lowering of sperm
quality and quantity, increased infertility,
and spontaneous abortion rates in humans
suggest that environmental estrogens play a
role in the toxicology of human reproduc-
tion and development (27,28). An objec-
tive causal relationship between detrimental
Volume 103, Supplement 7, October 1995 117SOTO ETAL.
Table 5. Xenobiotics tested bythe E-SCREEN assay.
Estrogenic xenobiotics
Herbicides
None 2,4-D
Alachlor
Butylate
Dacthal
Hexazinone
Propazine
Trifluralin
Insecticides
p,p'-DDT
o,p'-DDT
o,p'-DDE
p,p'-DDE
DDTa
Dieldrin
Chlordecone (kepone)
Endosulfana
a-Endosulfan
P-Endosulfan
Methoxychlor
Toxaphene
Fungicides
None
Industrial chemicals
2,3,4-TCB
2,2',4,5-TCB
2,3,4,5-TCB
2,4,4',6-TCB
2,2',3,3',6,6'-HCB
2-OH-2',5'-DCB
3-OH-2',5'-DCB
4-OH-2',5'-DCB
4-OH-2,2',5-TCB
4-OH-2',4',6'-TCB
3-OH-2',3',4',5'-TCB
4-OH-2',3',4',5'-TCB
4-OH-alkyl-phenols
Bisphenol-A
4-OH-biphenyl
t-Butylhydroxyanisole
Benzylbutylphthalate
aDenotes a technical grade isomer mixture.
Nonestrogenic xenobiotics
2,4-DB
Atrazine
Cyanazine
Dinoseb
Metolachlor
Picloram
Simazine
Bendiocarb
Chlordane
Diazinon
Heptachlor
Kelthane
Malathion
Methoprene
Parathion
Rotenone
Chlorothalonil
Hexachlorobenzene
Maneb
Metiram
Butylated hydroxytoluene
2,5-DCB
2,6-DCB
3,5-DCB
2,3',5-TCB
2,3,4,4'-TCB
2,3,4,5,6-PCB
2-OH-2',3',4',5,5'-PCB
2-OH-3,5-DCB
4-OH-3,5-DCB
1,2-Dichloropropane
Irganox 1640
2,3,7,8-TCDD
Tetrachloroethylene
Carbofuran
Chlordimeform
Chlorpyrifos
Carbaryl
Lindane
Mirex
Pyrethrum
Thiram
Zineb
Ziram
2-CB
4-CB
2,3,6-TCB
2,3,5,6-TCB
2,3,3'4,5'-PCB
2,2',3,3',5,5'-HCB
DecaCB
Diamyl phthalate
Dibutyl phthalate
Dimethyl isophthalate
Dimethyl terephthalate
Dinonyl phthalate
Octachlorostyrene
Styrene
Table 6. Estrogenic effect of pesticides according to
the E-SCREEN assay.
Compound Concentration RPE, % RPP, %
Estradiol 10pM 100 100
DDT* 10 pM 79.61 0.0001
o,p'-DDT 10 pM 86.14 0.0001
p,p'-DDT 10 pM 71.00 0.0001
Dieldrin 10 pM 54.89 0.0001
Endosulfan* 10 pM 81.25 0.0001
,B-Endosulfan 10 pM 78.26 0.0001
ax-Endosulfan 10 pM 77.17 0.0001
1-Hydroxychlordene 10 pM 40.00 0.0001
Kepone 10pM 84.00 0.0001
Toxaphene 10 pM 51.90 0.0001
Methoxychlor 10 pM 57.00 0.0001
Concentration describes the dose at which an estro-
genic effect is detected; maximal cell yield is obtained
at concentrations between 10 and 100 pM estradiol.
Most xenobiotics are active at 10 pM. The RPE mea-
sures the ratio between the maximal cell yield
achieved by the xenobiotic and that of estradiol. The
RPP measures the ratio between the dose of estradiol
and that of xenobiotic needed to achieve a prolifera-
tive effect. Asterisks (*) denote that the compound
referred to was oftechnical grade.
Table 7. Effect of xenoestrogens on progesterone
receptor and pS2 levels.
Concen-
Compound tration PRa pS2b
Control - 7.9±5.4 53.9± 16.7
Estradiol 1 nM 153.1 +49.5* 179.6±50.2
Endosulfan 1 pM 71.0± 13.1 * 129.2±6.2*
Endosulfan 10 pM 136.0±27.2* 172.1 ±61.6*
Toxaphene 1 pM 18.1 ±9.2 59.9±6.2
Toxaphene 10 pM 128.7 ±19.1* 108.0±17.6*
Dieldrin 1 pM 8.2± 1.7 210.3±29.9*
Dieldrin 10 pM 32.3± 11.7 232.7±32.6*
aProgesterone receptor (PR) levels are expressed as
femtomoles per mg cellular protein. bpS2 levels in the
culture medium are expressed as ng/106 cells. Each
result represents the mean ±SD of three experiments.
An asterisk(*) denotes a significant difference with the
hormoneless control (p<0.05).
health effects and their presumed causation
by xenoestrogens is tempered however by
the lack of appropriate technology to
explore this subject on a large scale. The
first obstacle encountered is that the estro-
genicity of chemicals cannot be predicted
solely on structural bases; therefore, it is
unknown how manyxenoestrogens are pre-
sent in the ecosystem. The E-SCREEN
bioassay is a reliable tool to rapidly assess
estrogenicity on a large number of com-
pounds; in this paper we describe how its
use helped to identify estrogens among
environmental pollutants. The second
obstacle to overcome is how to identify
causal agents when signs of estrogen
exposure have been verified. The finding of
reproductive effects caused by xenobiotics
has largely been accidental. For example,
workers at a kepone-producing plant devel-
oped azoospermia and impotence (29); this
was the first observation of reproductive
toxicity by kepone. Because of the occupa-
tional nature ofthis case, the culprit kepone
became readily apparent. In contrast,
wildlife are exposed to a combination of
xenobiotics. It became clear in the Great
Lakes studies that it was difficult to sort out
which one of the xenobiotics played a
causal role or whether the signs ofintoxica-
tion were due to cumulative interaction
among the chemicals present in affected
Table 8. Effect of xenoestrogens on estrogen receptor
processing.
Compound Concentration Estrogen receptora
Control - 183.9±59
Estradiol 1 nM 92.3±23.1
Endosulfan 1 pM 205.1 ±21.7c
Endosulfan 10 pM 238.3± 17.6c
Toxaphene 1 pM 261.9±1521,c
Toxaphene 10 pM 288.7±31.7bc
Dieldrin 1 pM 236.3±21.2bc
Dieldrin 10 pM 252.2±17.1 ,c
aEstrogen receptor levels are expressed as femto-
moles/mg cellular protein. Each result represents the
mean ±SD of at least three experiments. bDenotes a
statistically significant difference with the hormone-
less control. cDenotes a statistically significant differ-
ence with the estradiol-treated group(p<0.05).
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Table 9. Relative binding affinities (RBAs) and IC50 values of xenoestrogens.
Compound RBA RPP IC50 Concentration*
Estradiol 100 100 1.5±0.4 nM 100pM
,B-Endosulfan 0.00024 0.0001 631.0±88 pM 10 pM
Toxaphene 0.00032 0.0001 470.0±38 pM 10pM
o,p'-DDT 0.00031 0.0001 485.0±42 pM 10 pM
p-Nonylphenol 0.021 0.001 7.2±3 pM 1 pM
*Concentration needed for maximal proliferative effect. All xenoestrogen IC50 values were significantly different
from that of estradiol.
animals (1). Exposure to environmental
estrogens, singly or in combination, may
be easily assessed in male fish, reptiles, or
birds used as sentinels by measuring their
vitellogenin plasma levels. Instead, expo-
sure of females to xenoestrogens is more
difficult to ascertain through a marker such
as vitellogenin because the serum levels of
this protein are high in animals laying eggs
(30,31). In addition, there is no compara-
ble marker to ascertain exposure in
mammals. Again, the E-SCREEN assay
represents the best alternative to resolve
this second obstacle.
Animal Bioassays andtheE-SCREEN
Assay: Differences andSimilarities
Diverse animal models and assays have
been used to measure estrogenicity. Allen
and Doisy (32) and other pioneers of
estrogen research used mouse and rat
activity units to follow their estrogen
purification protocol; the end point of
their assay was vaginal cornification.
Dodds and Lawson(33) used both the
Allen and Doisy assay (32) and the femi-
nization of the feather pattern in brown
leghorn capons (33). Others adopted the
uterotropic assay using single or multiple
doses of estrogens over 24- to 72-hr peri-
ods in immature or ovariectomized mice
and rats. This diversity ofend points indi-
cates that there is no universal "gold stan-
dard" of estrogen action among animal
bioassays. The E-SCREEN assay appears to
be the best candidate for establishing a
quantitative standard of estrogenic activity
at the target organ level. As shown in
Tables 1 through 6, no false positives or
negatives were observed among the estro-
gens and nonestrogens tested.
No qualitative differences could be
found when comparing animal assays and
the E-SCREEN assay; that is, the estro-
genic properties of compounds character-
ized using animal bioassays was also
ascertained using the E-SCREEN test.
From a pharmacokinetic perspective, the
latter measures estrogenicity at the target
cell level under conditions where estrogen
levels are mostly constant, much like the
ones achieved when animals are treated
with estrogen-filled silastic implants. This
approach is more relevant to chronic envi-
ronmental exposure than that ofmeasuring
acute effects after a single dose. In both
types ofassays, metabolism ofthe suspected
xenoestrogen into more or less active com-
pounds is uncertain and should be defined
individually for each compound. For exam-
ple, nonylphenol diethoxylate was estro-
genic for MCF-7 cells; since it does not
compete for estradiol binding to the estro-
gen receptor, it is likely that estrogenic
activity results from nonylphenol diethoxy-
late metabolism to the free phenol (22).
Methoxychlor was also believed to be inac-
tive until metabolized to free phenols, pre-
sumably in the liver; again, methoxychlor
tested positive when assayed by the E-
SCREEN test. Therefore, even though the
putative proestrogens tested so far were
estrogenic when assayed by the E-
SCREEN test, an added step in the quest
for identifying all xenoestrogens may
include their metabolic activation by liver
microsome extracts prior to their testing by
the E-SCREEN assay.
Regarding quantitative effects, while
kepone is 100,000 to 1,000,000 times less
potent than estradiol according to the
E-SCREEN assay, an increase of the rat
uterine wet weight comparable to that of
estradiol occurred with a 1000- to 5000-fold
higher dose of chlordecone than that of
estradiol (3). This discrepancy may be due
to rapid metabolism ofestradiol and persis-
tence and bioaccumulation of chlordecone
in animals. Differences between results in
culture and in live animals reflect the dif-
ferent parameters used as a measure of
estrogenicity. On one hand, the rodent
assay measures the increase of uterine wet
weight [water imbibition, hypertrophy
(which is also produced by estrogen antag-
onists), and hyperplasia] (5), while on the
other hand, the human E-SCREEN bio-
assay measures cell proliferation only. This
is a necessary and sufficient parameter to
define estrogen action (2).
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Figure 3. Proliferative activity of A, hormoneless con-
trol; B, 10 pM 1-endosulfan; C, lpM 3-endosulfan; D,
1 pM a-endosulfan; E, 1 pM toxaphene; F, 1 pM dield-
rin; G, 1 pM 2,3,4,5-tetrachlorobiphenyl; H, 1 pM p,p'-
DDT; I, 1 pM 2,2',3,3',6,6'-hexachlorobiphenyl; J, 1 pM
p,p'-DDD; K, 1 pM p,p'-DDE; L, 1 pM methoxychlor;
and M, mixture of the 10 chemicals indicated as C to L,
each at 1 pM. Asterisks (*) indicate significant differ-
ences with hormoneless control (p<0.05).
New Estrogns Identfiedbythe
E-SCREENAssay
Novel xenoestrogens were found among
antioxidants, plasticizers, polychlorinated
biphenyl (PCB) congeners, and pesticides.
Alkylphenols are used as antioxidants
and in the synthesis of detergents
[alkylphenol polyethoxylates, (APEs)].
APEs are used as industrial detergents in
the textile and paper industries, in toi-
letries, and as spermicides. Four hun-
dred and fifty million pounds of APEs
were sold in the United States in 1990.
APEs are not estrogenic per se; however,
they are degraded during sewage treat-
ment. The polyethoxylate chain is
shortened, and free alkylphenols as well
as mono and diethoxylates are pro-
duced. The free phenols are estrogenic
(9,10). Recently, White et al. (22) have
shown that the diethoxylates are also
estrogenic. These APE degradation
products have been detected in drinking
water (34). Nonylphenol has been
reported to leach from PVC tubing for
milk processing (35) and plastics used
in food packaging (36). APEs such as
those used as spermicides are degraded
to free nonylphenol when administered
to rodents (37). The contribution of
APEs and alkylphenols to the xenoestro-
gen burden of humans is unknown;
however, it has been reported that these
chemicals are present in sewage outlets
in concentrations sufficient to feminize
sentinel fish (38). Alkylphenols accu-
mulate in river sediment and in the fat
of exposed fish (39). Some phenolic
antioxidants such as butylated hydroxy-
toluene (BHT) and t-butylhydroxy-
anisole (BHA) are used to prolong the
shelf life of foodstuffs and to reduce
Volume 103, Supplement 7, October 1995 1 19SOTOETAL.
nutritional losses by retarding oxidation.
Interesting observations pertaining to
structure-function relationships were
made: a) the alkyl chain must at least
have 3 carbons; b) the p-isomers are
more potent estrogens than the m-iso-
mers; c) polyalkylated, hindered phenols
like BHT and Irganox 1640 (Ciba-
Geigy, Basel, Switzerland) are not estro-
genic while being effective antioxidants;
and d) fused rings like naphthols are
not estrogenic in spite ofbeing an inte-
gral part ofthe A and B ring ofnatural
steroids. Instead, substituted naphthols
such as 6-Br naphthol and allenolic acid
are estrogenic; more studies are needed
to assess whether these substituted
naphthols are active due to a bulk effect,
electronegativity, or because flat mole-
cules sucli as naphthols and coplanar
PCBs are unable to bind tightly to the
estrogen receptor.
In addition to the estrogenic alkylphenol
antioxidants described above, we found that
BHA was estrogenic. BHA is a widely used
antioxidant; because it controls oxidation of
short-chain fatty acids such as coconut oil
(40). Maximal usage levels ofBHA permit-
ted by U.S. Food and Drug Administration
(U.S. FDA) varies according to the food
type, from 50 ppm in dry breakfast cereals
to 1000 ppm in active yeast (41).
Plasticizers are used to decrease the
rigidity of certain polymers. For the
most part, they are di- and triesters of
organic acids. Phthalate esters are widely
used plasticizers (42). These compounds
leach from plastics, and they have been
found to be ubiquitously distributed in
the environment, including marine
ecosystems (43,44). Among phthalate
esters butyl benzyl phthalate was estro-
genic whereas those derived from alkyl
alcohols such as dibutyl phthalate and
diamyl phthalate were not.
* Aroclor 1221 was not estrogenic by the
E-SCREEN assay (data not shown).
Many congeners are present in Aroclor
mixtures; therefore, it is likely that the
maximal concentration used, 10 pM,
resulted in levels of individual con-
geners lower than those needed to
induce cell proliferation. PCB mixtures
such as Aroclor 1221 were reported to
be estrogenic using uterotropic assays as
end points (increased uterine wet
weight, increased uterine glycogen con-
tent) (45). However, the magnitude of
the uterine wet weight increase was
only marginally significant, analyzed by
inappropriate statistical tests and lower
than that achieved with E2 or DDT
(45,46). Therefore, the estrogenicity of
PCB mixtures would be best ascer-
tained by first determining which con-
geners are estrogenic. Korach et al. (47)
demonstrated the ability of certain
hydroxy-PCBs to bind to estrogen
receptors and to produce an uterotropic
effect that correlated with their relative
binding affinity to the estrogen recep-
tor. It is generally assumed that hydrox-
ylated PCBs are estrogenic while
nonhydroxylated PCBs are not. In this
paper we show that 5 of the 18 con-
geners studied were estrogenic in the
E-SCREEN assay (Table 4). It is
unknown whether they were estrogenic
per se or they were hydroxylated by
MCF-7 cells; hydroxylated PCBs are
more potent than their nonhydroxy-
lated counterparts. The phenyl rings in
the active compounds were not copla-
nar. Among the hydroxylated PCBs,
those p-hydroxylated were more potent
than m-hydroxylated; o-hydroxylated
compounds were even less active.
Hindered phenols, such as in 4-OH-
3,5,-DCB were less estrogenic than
unobstructed ones.
The pesticides dieldrin and toxaphene
are estrogenic. Their use has been
restricted in the United States since
1974 and 1982, respectively (23).
These compounds are highly lipophilic
and bioaccumulate in ecosystems; they
are still found in wildlife, coincidentally
with signs of reproductive impairment.
Toxaphene is a main airborne pollutant
in North America, and its residues
appeared in regions where it has never
been used, like the Arctic and
Scandinavia (48). It is present in Arctic
and Baltic salmon muscle fat at concen-
trations of 700 to 7000 ppb (49); this
concentration is well within those
producing estrogenic effects in the
E-SCREEN assay (10 pM =4800 ppb).
Endosulfan was introduced in 1954; it
is presently used for agricultural purposes
in the United States and other countries
(50). Proliferative, estrogenlike effects in
MCF-7 cells were found at doses of 10 pM
(4060 ppb). Endosulfan was shown to pro-
duce testicular atrophy in male rats fed a
diet containing 10 ppm (51,52); it also
lowered gonadotrophin and testosterone
plasma levels (53). These results are consis-
tent with its estrogenicity revealed by the
E-SCREEN test.
These newly identified estrogens not
only induced cell proliferation but pS2 and
PR as well; this confirms their estrogen-
mimicking properties and the specificity of
the E-SCREEN assay as a tool to identify
estrogens. These xenoestrogens compete
with estradiol for binding to its receptor;
their RBA's correlated well with their
potency to induce cell proliferation, pS2,
and PR. Recent data suggest that alkylphe-
nols bind to the estrogen-binding domain
of the estrogen receptor (22). Binding to
the receptor is a necessary but insufficient
property to define estrogenicity. Tetra-
hydronaphthol, which is not estrogenic, is
effective in preventing the forward binding
of estradiol to its receptor while alkylphe-
nols, which are estrogenic, are effective in
displacing prebound estradiol from its
receptor (54). These data were interpreted
as indicative ofinteractions with more than
one site on the estradiol receptor.
CumulativeEffectofXenoestrogens
Xenoestrogens may act cumulatively (Figure
3) and with endogenous estrogens thus dis-
rupting the endocrine system of exposed
wildlife and humans. Hence, measuring
the total estrogenic burden due to envi-
ronmental contaminants present in a
plasma/tissue sample may be more mean-
ingful than to assess exposure by measur-
ing the levels of each of the known
xenoestrogens. Recently, an epidemiologi-
cal study showed a positive correlation
between breast cancer and serum levels of
DDE, a DDT metabolite (55-57), leaving
open the possibility that xenoestrogen expo-
sure increases the incidence of breast can-
cer. Since xenoestrogens are postulated to
be a risk factor for breast cancer, measuring
a single xenoestrogen may not be a reliable
indicator ofexposure because different per-
sons eating different diets may be exposed
to different xenoestrogens. Therefore, mea-
suring total xenoestrogen burden represents
a more reliable approach to assess the link
between xenoestrogens and breast cancer.
The E-SCREEN test may be used to this
end once a protocol is developed to separate
environmental estrogens from endogenous
ones. In addition, in a preventive approach,
the E-SCREEN test may be used to screen
chemicals for their estrogenicity before they
are released into the environment.
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